Cart
sales@molnova.com
WDR5-MLL1 inhibitor
CAS No. 2216002-17-2
WDR5-MLL1 inhibitor ( —— )
Catalog No. M13532 CAS No. 2216002-17-2
WDR5-MLL1 inhibitor is a novel potent inhibitor of WDR5-MLL1 interaction, binds to WDR5 with Kd of 1 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameWDR5-MLL1 inhibitor
-
NoteResearch use only, not for human use.
-
Brief DescriptionWDR5-MLL1 inhibitor is a novel potent inhibitor of WDR5-MLL1 interaction, binds to WDR5 with Kd of 1 nM.
-
DescriptionWDR5-MLL1 inhibitor is a novel potent inhibitor of WDR5-MLL1 interaction, binds to WDR5 with Kd of 1 nM.
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetHMTase
-
RecptorHMTase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2216002-17-2
-
Formula Weight405.50
-
Molecular FormulaC24H27N3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameN-(5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-2-yl)-2-isopropoxybenzyl)-3-methoxybenzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. US Patent US 2018086767.
molnova catalog
related products
-
MI-136
A potent Menin-MLL interaction inhibitor with IC50 of 31 nM.
-
OICR-9429
A potent, selective, small-molecule antagonist of WDR5-MLL interaction that binds to WDR5 with Kd of 93±28 nM.
-
EZM 2302
EZM 2302 (EZM2302, GSK 3359088)is a potent, selective, orally available arginine methyltransferase CARM1 inhibitor with IC50 of 6 nM.
